全文获取类型
收费全文 | 49733篇 |
免费 | 5061篇 |
国内免费 | 113篇 |
专业分类
耳鼻咽喉 | 469篇 |
儿科学 | 1265篇 |
妇产科学 | 1200篇 |
基础医学 | 7388篇 |
口腔科学 | 1077篇 |
临床医学 | 6079篇 |
内科学 | 9188篇 |
皮肤病学 | 573篇 |
神经病学 | 4892篇 |
特种医学 | 1908篇 |
外国民族医学 | 57篇 |
外科学 | 6367篇 |
综合类 | 1073篇 |
一般理论 | 46篇 |
预防医学 | 5454篇 |
眼科学 | 1216篇 |
药学 | 3767篇 |
中国医学 | 32篇 |
肿瘤学 | 2856篇 |
出版年
2021年 | 709篇 |
2020年 | 450篇 |
2019年 | 707篇 |
2018年 | 799篇 |
2017年 | 611篇 |
2016年 | 677篇 |
2015年 | 735篇 |
2014年 | 1081篇 |
2013年 | 1691篇 |
2012年 | 2319篇 |
2011年 | 2378篇 |
2010年 | 1392篇 |
2009年 | 1208篇 |
2008年 | 2219篇 |
2007年 | 2247篇 |
2006年 | 2280篇 |
2005年 | 2185篇 |
2004年 | 2231篇 |
2003年 | 1938篇 |
2002年 | 1906篇 |
2001年 | 1504篇 |
2000年 | 1633篇 |
1999年 | 1398篇 |
1998年 | 627篇 |
1997年 | 545篇 |
1996年 | 491篇 |
1995年 | 498篇 |
1994年 | 459篇 |
1993年 | 428篇 |
1992年 | 1084篇 |
1991年 | 1125篇 |
1990年 | 1036篇 |
1989年 | 1013篇 |
1988年 | 1013篇 |
1987年 | 886篇 |
1986年 | 876篇 |
1985年 | 849篇 |
1984年 | 712篇 |
1983年 | 589篇 |
1982年 | 392篇 |
1981年 | 366篇 |
1980年 | 352篇 |
1979年 | 669篇 |
1978年 | 520篇 |
1977年 | 446篇 |
1976年 | 415篇 |
1975年 | 383篇 |
1974年 | 442篇 |
1973年 | 439篇 |
1972年 | 377篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
Tihana Bicanic Christian Bottomley Angela Loyse Annemarie E. Brouwer Conrad Muzoora Kabanda Taseera Arthur Jackson Jacob Phulusa Mina C. Hosseinipour Charles van der Horst Direk Limmathurotsakul Nicholas J. White Douglas Wilson Robin Wood Graeme Meintjes Thomas S. Harrison Joseph N. Jarvis 《Antimicrobial agents and chemotherapy》2015,59(12):7224-7231
Amphotericin B deoxycholate (AmBd) is the recommended induction treatment for HIV-associated cryptococcal meningitis (CM). Its use is hampered by toxicities that include electrolyte abnormalities, nephrotoxicity, and anemia. Protocols to minimize toxicity are applied inconsistently. In a clinical trial cohort of AmBd-based CM induction treatment, a standardized protocol of preemptive hydration and electrolyte supplementation was applied. Changes in blood counts, electrolyte levels, and creatinine levels over 14 days were analyzed in relation to the AmBd dose, treatment duration (short course of 5 to 7 days or standard course of 14 days), addition of flucytosine (5FC), and outcome. In the 368 patients studied, the hemoglobin levels dropped by a mean of 1.5 g/dl (95% confidence interval [CI], 1.0 to 1.9 g/dl) following 7 days of AmBd and by a mean of 2.3 g/dl (95% CI, 1.1 to 3.6 g/dl) after 14 days. Serum creatinine levels increased by 37 μmol/liter (95% CI, 30 to 45 μmol/liter) by day 7 and by 49 μmol/liter (95% CI, 35 to 64μmol/liter) by day 14 of AmBd treatment. Overall, 33% of patients developed grade III/IV anemia, 5.6% developed grade III hypokalemia, 9.5% had creatinine levels that exceeded 220 μmol, and 6% discontinued AmBd prematurely. The addition of 5FC was associated with a slight increase in anemia but not neutropenia. Laboratory abnormalities stabilized or reversed during the second week in patients on short-course induction. Grade III/IV anemia (adjusted odds ratio [aOR], 2.2; 95% CI, 1.1 to 4.3; P = 0.028) and nephrotoxicity (aOR, 4.5; 95% CI, 1.8 to 11; P = 0.001) were risk factors for 10-week mortality. In summary, routine intravenous saline hydration and preemptive electrolyte replacement during AmBd-based induction regimens for HIV-associated CM minimized the incidence of hypokalemia and nephrotoxicity. Anemia remained a concerning adverse effect. The addition of flucytosine was not associated with increased neutropenia. Shorter AmBd courses were less toxic, with rapid reversibility. 相似文献
982.
983.
Nima Abbasian James O. Burton Karl E. Herbert Barbara-Emily Tregunna Jeremy R. Brown Maryam Ghaderi-Najafabadi Nigel J. Brunskill Alison H. Goodall Alan Bevington 《Journal of the American Society of Nephrology : JASN》2015,26(9):2152-2162
Hyperphosphatemia in patients with advanced CKD is thought to be an important contributor to cardiovascular risk, in part because of endothelial cell (EC) dysfunction induced by inorganic phosphate (Pi). Such patients also have an elevated circulating concentration of procoagulant endothelial microparticles (MPs), leading to a prothrombotic state, which may contribute to acute occlusive events. We hypothesized that hyperphosphatemia leads to MP formation from ECs through an elevation of intracellular Pi concentration, which directly inhibits phosphoprotein phosphatases, triggering a global increase in phosphorylation and cytoskeletal changes. In cultured human ECs (EAhy926), incubation with elevated extracellular Pi (2.5 mM) led to a rise in intracellular Pi concentration within 90 minutes. This was mediated by PiT1/slc20a1 Pi transporters and led to global accumulation of tyrosine- and serine/threonine-phosphorylated proteins, a marked increase in cellular Tropomyosin-3, plasma membrane blebbing, and release of 0.1- to 1-μm-diameter MPs. The effect of Pi was independent of oxidative stress or apoptosis. Similarly, global inhibition of phosphoprotein phosphatases with orthovanadate or fluoride yielded a global protein phosphorylation response and rapid release of MPs. The Pi-induced MPs expressed VE-cadherin and superficial phosphatidylserine, and in a thrombin generation assay, they displayed significantly more procoagulant activity than particles derived from cells incubated in medium with a physiologic level of Pi (1 mM). These data show a mechanism of Pi-induced cellular stress and signaling, which may be widely applicable in mammalian cells, and in ECs, it provides a novel pathologic link between hyperphosphatemia, generation of MPs, and thrombotic risk. 相似文献
984.
Kenneth S. Brandenburg MS Diego F. Calderon DVM Patricia R. Kierski BA Amanda L. Brown BS Nihar M. Shah PhD Nicholas L. Abbott PhD Michael J. Schurr MD Christopher J. Murphy DVM PhD Jonathan F. McAnulty DVM PhD Charles J. Czuprynski PhD 《Wound repair and regeneration》2015,23(6):842-854
Chronic nonhealing skin wounds often contain bacterial biofilms that prevent normal wound healing and closure and present challenges to the use of conventional wound dressings. We investigated inhibition of Pseudomonas aeruginosa biofilm formation, a common pathogen of chronic skin wounds, on a commercially available biological wound dressing. Building on prior reports, we examined whether the amino acid tryptophan would inhibit P. aeruginosa biofilm formation on the three‐dimensional surface of the biological dressing. Bacterial biomass and biofilm polysaccharides were quantified using crystal violet staining or an enzyme linked lectin, respectively. Bacterial cells and biofilm matrix adherent to the wound dressing were visualized through scanning electron microscopy. d ‐/l ‐tryptophan inhibited P. aeruginosa biofilm formation on the wound dressing in a dose dependent manner and was not directly cytotoxic to immortalized human keratinocytes although there was some reduction in cellular metabolism or enzymatic activity. More importantly, d ‐/l ‐tryptophan did not impair wound healing in a splinted skin wound murine model. Furthermore, wound closure was improved when d ‐/l ‐tryptophan treated wound dressing with P. aeruginosa biofilms were compared with untreated dressings. These findings indicate that tryptophan may prove useful for integration into wound dressings to inhibit biofilm formation and promote wound healing. 相似文献
985.
986.
987.
Effect of a genomic classifier test on clinical practice decisions for patients with high‐risk prostate cancer after surgery 下载免费PDF全文
988.
989.
D. E. Stewart S. M. Tlusty K. H. Taylor R. S. Brown H. N. Neil D. K. Klassen J. A. Davis T. M. Daly P. C. Camp A. M. Doyle 《American journal of transplantation》2015,15(12):3123-3133
Analysis and dissemination of transplant patient safety data are essential to understanding key issues facing the transplant community and fostering a “culture of safety.” The Organ Procurement and Transplantation Network's (OPTN) Operations and Safety Committee de‐identified safety situations reported through several mechanisms, including the OPTN's online patient safety portal, through which the number of reported cases has risen sharply. From 2012 to 2013, 438 events were received through either the online portal or other reporting pathways, and about half were self‐reports. Communication breakdowns (22.8%) and testing issues (16.0%) were the most common types. Events included preventable errors that led to organ discard as well as near misses. Among events reported by Organ Procurement Organization (OPOs), half came from just 10 of the 58 institutions, while half of events reported by transplant centers came from just 21 of 250 institutions. Thirteen (23%) OPOs and 155 (62%) transplant centers reported no events, suggesting substantial underreporting of safety‐related errors to the national database. This is the first comprehensive, published report of the OPTN's safety efforts. Our goals are to raise awareness of safety data recently reported to the OPTN, encourage additional reporting, and spur systems improvements to mitigate future risk. 相似文献
990.
A. K. Nowocin K. Brown L. A. Edwards L. Meader J. I. Hill W. Wong 《American journal of transplantation》2015,15(9):2491-2494
The mouse heterotopic cardiac transplantation model has been used extensively by investigators in the field of organ transplantation to study the rejection process, test new antirejection treatments, tolerance induction protocols or to understand basic immunological principles. Due to its extensive use, any small refinement of the technique would have a major impact on replacement, reduction and refinement (commonly known as the 3Rs). Here, we describe a novel approach to refine this model. The donor aorta and pulmonary artery are anastomosed peripherally to the femoral artery and vein of the recipient, respectively. The technical success rate is comparable to the conventional abdominal site, but it avoids a laparotomy and handling of the bowels making it less invasive method. As a result, recipients recover faster and require less postoperative analgesia. It is a major refinement under one of the 3Rs and would represent an advance in animal welfare in scientific research. 相似文献